{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IDE"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDE\",,,,,undefined,":{"symbol":"IDE","market":"US","secType":"STK","nameCN":"Voya Infrastructure Industrials and Materials Fund","latestPrice":10.5,"timestamp":1743432938095,"preClose":10.55,"halted":0,"volume":11653,"delay":0,"floatShares":0,"shares":19279000,"eps":0,"marketStatus":"Trading","change":-0.05,"latestTime":"03-31 10:55:57 EDT","open":10.49,"high":10.539,"low":10.476,"amount":122218.17889,"amplitude":0.005972,"askPrice":10.76,"askSize":100,"bidPrice":10.46,"bidSize":6,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743451200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":10.55,"aum":0,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":10.55,"preClose":10.55,"latestTime":"16:05 EDT","volume":3,"amount":31.65,"timestamp":1743192313017},"volumeRatio":1.227498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDE\",,,,,undefined,":{"symbol":"IDE","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.227498,"shares":19279000,"dividePrice":1.2,"high":10.539,"amplitude":0.005972,"preClose":10.55,"low":10.476,"week52Low":9.8416,"pbRate":"--","week52High":11.766,"institutionHeld":0,"latestPrice":10.5,"committee":-0.886792,"eps":0,"divideRate":0.114286,"volume":11653,"delay":0,"ttmEps":0,"open":10.49,"prevYearClose":10.15,"prevWeekClose":10.55,"prevMonthClose":10.53,"prevQuarterClose":10.15,"fiveDayClose":10.58,"twentyDayClose":10.46,"sixtyDayClose":10.15},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IDE\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDE\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522306934","title":"Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms","url":"https://stock-news.laohu8.com/highlight/detail?id=2522306934","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522306934?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:00","pubTimestamp":1743080400,"startTime":"0","endTime":"0","summary":"Abbott's Volt PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation. Pulsed field ablation – or PFA – uses high energy electrical pulses for ablation procedures that may offer benefits to targeting and treating tissue in the heart. Abbott's Volt PFA System is designed to overcome limitations of existing PFA systems, providing improved workflows and a clearer indication of contact between the Volt PFA catheter and targeted tissue. ABBOTT PARK, Ill., March 27, 2025 /PRNewswire/ -- Abbott  today announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation . With the earlier-than-expected CE Mark, Abbott has begun commercial PFA cases in the EU with physicians who have already gained experience with the Volt PFA System within Abbott's PFA clinical studies. The company will further expand use of Volt in EU markets throughout the second half of the year.Volt PFA Syste","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/abbott-receives-ce-mark-volt-130000876.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abbott-receives-ce-mark-volt-130000876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0009355771.USD","SGXZ23171101.USD","LU2237957811.SGD","LU2237957902.USD","IDE","LU1989763690.USD","IE00BJJMRZ35.SGD","BK4504","LU1691799644.USD","PVI","IE0002141913.USD","SG9999004303.SGD","BK4581","ABT","LU2133065610.SGD","IE00BFTCPJ56.SGD","BK4588","LU1061106388.HKD","SG9999002224.SGD","LU2112291526.USD","LU0234572021.USD","IE00B2B36J28.USD","LU1721429741.USD","LU0170899867.USD","BK4566","SG9999002232.USD","LU2089984988.USD","BK4568","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2468319806.SGD","EP","BK4585","BK4592","LU1057294990.SGD","BK4533","BK4213","BK4082","BK4109","CE","IE00BJT1NW94.SGD","LU0122379950.USD","LU1721429402.USD","LU1914381329.SGD","LU1989763427.SGD","LU0266013472.USD","LU0868494617.USD"],"gpt_icon":0},{"id":"2522074303","title":"Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522074303","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522074303?lang=en_us&edition=fundamental","pubTime":"2025-03-25 21:25","pubTimestamp":1742909100,"startTime":"0","endTime":"0","summary":"At 6 months, the WRAPSODY CIE achieved 89.8% and 72.6% target lesion primary patency and access circuit primary patency, respectively.At 12 months, the WRAPSODY CIE achieved 70.1% and 58.1% target les","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/25/3048850/8028/en/Merit-Medical-Releases-12-Month-Efficacy-Results-of-the-WRAPSODY-Cell-Impermeable-Endoprosthesis-CIE.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","CE","LU1559883803.SGD","BK4198","MMSI","LU0566484027.USD","WAVE","IDE","BK4539","BK4133","BK4109"],"gpt_icon":0},{"id":"2522009664","title":"ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System","url":"https://stock-news.laohu8.com/highlight/detail?id=2522009664","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522009664?lang=en_us&edition=fundamental","pubTime":"2025-03-25 21:16","pubTimestamp":1742908560,"startTime":"0","endTime":"0","summary":"Abbott ABT has received the FDA’s investigational device exemption  for its Coronary Intravascular Lithotripsy  system to evaluate the treatment of severe calcification in coronary arteries prior to stenting. The TECTONIC Coronary Artery Disease  Intravascular Lithotripsy  clinical trial will enroll up to 335 people in 47 sites in the United States.The company’s investigational Coronary IVL technology builds upon its existing vascular portfolio, part of the Medical Devices segment, and is designed to address the challenges of currently available IVL systems.Per a Research report, the global CAD market was valued at $22.07 billion in 2024 and is set to witness a compound annual rate of 8.9% through 2031. The rising CAD prevalence around the world fuels the market’s growth, along with higher funding for research and development of therapies and an increase in comorbid conditions, including atherosclerosis and hypertension.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abt-stock-gain-fda-ide-131600566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0154236417.USD","LU1267930490.SGD","LU1571399168.USD","LU0048584097.USD","LU2242649171.HKD","CAH","LU2237957902.USD","LU1291159041.SGD","ABT","LU0122379950.USD","LU0238689110.USD","LU1914381329.SGD","LU0162691827.USD","LU2506952097.USD","LU0266013472.USD","SG9999001440.SGD","LU0868494617.USD","LU0310800965.SGD","LU0211327993.USD","LU0187121727.USD","LU1791710582.SGD","BK4533","BK4196","LU0170899867.USD","LU2087625088.SGD","IE00BFTCPJ56.SGD","LU2468319806.SGD","SG9999002232.USD","IE0002141913.USD","LU0011850046.USD","IDE","LU0251132253.USD","LU1983299246.USD","LU1989764748.USD","LU0072461881.USD","BK4588","LU0823417737.USD","LU2506951958.HKD","LU2362541513.USD","IE0009355771.USD","LU2491050154.USD","BK4568","BK4175","LU0114720955.EUR","LU0310799852.SGD","BSX","LU1791710400.SGD","LU1718418525.SGD"],"gpt_icon":1},{"id":"2522002742","title":"Datavault AI Licenses Patented ADIO Technology to NYIAX, Ushering in a New Era of Ultrasonic Advertising","url":"https://stock-news.laohu8.com/highlight/detail?id=2522002742","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522002742?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:57","pubTimestamp":1742903820,"startTime":"0","endTime":"0","summary":"Licensing Deal Strengthens Focus on Information Data Exchange While Introducing a Privacy-First Advertising Category. BEAVERTON, Ore., March 25, 2025----Datavault AI Inc. , a leader in AI-driven data valuation and monetization, today announced a strategic licensing agreement with NYIAX, the Nasdaq-powered trading platform. This agreement integrates Datavault AI’s patented ADIO technology into NYIAX’s cutting-edge advertising exchange, creating one of the world’s first fully functional ultrasonic advertising platforms. Technical integration is expected to be completed in Q2 2025, with combined product offerings available for customer deployments in 2H 2025.\"Authenticated scalability and direct consumer engagement are no longer optional for brands seeking competitive differentiation,\" said Joseph Stonbely II, Founder & Executive Producer of Mission: IGNITION  \"We’ve long considered the NYIAX platform our most essential front-line resource for delivering meaningful, value-engineered brand","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/datavault-ai-licenses-patented-adio-115700241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","QID","BK4166","SQQQ","TQQQ","BK4141","NQmain","ML","USAW.SI","NVIW.SI","MNQmain","DVLT","IDE","TSYW.SI","USJW.SI","PSQ",".IXIC"],"gpt_icon":1}],"pageSize":4,"totalPage":23,"pageCount":1,"totalSize":89}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDE\",params:#limit:5,,,undefined,":[{"date":"2025-04-01","symbol":"IDE","amount":0.1,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-01","defaultRemindTime":1743514200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-15","payableDate":"2025-04-01","currency":"USD","dateTimestamp":1743480000000,"payDate":"2025-04-15"},{"date":"2025-03-03","symbol":"IDE","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-17","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-17"},{"date":"2025-02-03","symbol":"IDE","amount":0.1,"announcedDate":"2025-01-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-03","defaultRemindTime":1738593000000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-18","payableDate":"2025-02-03","currency":"USD","dateTimestamp":1738558800000,"payDate":"2025-02-18"},{"date":"2024-12-30","symbol":"IDE","amount":0.1,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-15","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-15"},{"date":"2024-12-02","symbol":"IDE","amount":0.1,"announcedDate":"2024-11-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-02","defaultRemindTime":1733149800000,"name":"Voya Infrastructure Industrials and Materials Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-16","payableDate":"2024-12-02","currency":"USD","dateTimestamp":1733115600000,"payDate":"2024-12-16"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDE\",market:\"US\",,,undefined,":[{"executeDate":"2015-04-01","recordDate":"2015-04-06","paymentDate":"2015-04-15","value":0.405,"currency":"USD"},{"executeDate":"2015-07-01","recordDate":"2015-07-06","paymentDate":"2015-07-15","value":0.405,"currency":"USD"},{"executeDate":"2015-10-01","recordDate":"2015-10-05","paymentDate":"2015-10-15","value":0.365,"currency":"USD"},{"executeDate":"2015-12-29","recordDate":"2015-12-31","paymentDate":"2016-01-15","value":0.365,"currency":"USD"},{"executeDate":"2016-04-01","recordDate":"2016-04-05","paymentDate":"2016-04-15","value":0.365,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDE\",market:\"US\",delay:false,,,undefined,":{}}}